In 1998, Dr. Clay Seigall founded Seattle Genetics, Inc. He serves as the Chairman of the Board and Chief Executive Officer. His focus at this biotechnology company is on diseases that haven’t had mortality rates improve in years or even decades. He has a Ph.D. in Genetics which he earned from George Washington University located in Washington D.C.
Seattle Genetics, under Dr. Clay Seigall’s amazing leadership, has established itself as one of the preeminent companies that are involved in targeted therapy. Currently and in the past, most therapies harmed healthy cells as well as diseased ones. Through researching antibody-drug conjugates, Dr. Seigall has developed therapies that kill diseased cells while leaving healthy cells undamaged. This, according to him, is the wave of the future and will completely supplant conventional disease therapies as time goes on and more targeted therapies are developed.
When Dr. Seigall founded Seattle Genetics, it was a very tight team of just enough researchers to get the company going. It is now a big player in the biotechnology industry, especially when it comes to cancer targeted therapies. His first drug was approved by the FDA in the late 2000’s and is helping people beat lymphoma around the world. His company has more than 20 antibody-drug conjugates under development, several of which show great promise.
Dr. Clay Seigall had two main reasons for founding Seattle Genetics. The first was that at his prior job at Bristol-Myers Squibb he was far too constrained in what he wanted to accomplish in his projects. The second reason is that he doesn’t feel that, as an employee of the company, that he was fairly compensated for what he had developed. One of his patents while working at Bristol earned the company more than $80 million but he didn’t see even a bump in his paycheck. He decided to start his own company so that he could fairly benefit from his research.
Another reason that Dr. Seigall founded Seattle Genetics is that he has a passion for curing diseases, especially cancer. He was only 24 when he saw his father die from cancer and this inspired him to dedicate his career to finding cures for this and other diseases.